Searched for
CARDIAC STENT MAKER
Cipla, Alkem Laboratories in final lap to buy SMTPromoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders also divest thei...- Govt mulls over new category for advanced coronary stents, price ceiling increase to attract manufacturersThe government is considering creating a separate category for advanced coronary stents and raising the price ceiling to attract stent make...
- Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMTMorgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias...
- Stent maker Sahajanand to sell 30% stake, eyes $300 mn valuationEstablished in 1998, SMT develops and manufactures cardiac products that are sold in 75 countries. Its portfolio includes coronary stents (...
- Stents price capping has improved its accessibility: Drug pricing regulator NPPAAccording to the National Pharmaceutical Pricing Authority (NPPA) both stent manufactured and imported went up from 9.36 lakh in 2016 to 13...
- Surgical strike! Prices of drug eluting stents cutCoronary stents are wire mesh tubes inserted into coronary arteries to clear blockages and prevent heart attacks.
- Drug eluting stents expected to get cheaperThe maximum price that patients should pay for drug eluting, bioresorbable vascular and biodegradable coronary stents was reduced to Rs 27,...
- Angioplasty cost falls up to 18 per cent on stent price capAngioplasty cost at corporate hospital chains came down by 8-12% to ₹2.05 lakh-2.20 lakh from ₹2.10 lakh-2.20 lakh, the study showed.
- Three MNC pharma companies want to recall its new generation stents from IndiaIt's not clear if firms can withdraw their products as the Department of Pharmaceuticals had recently prevented stent makers from taking th...
- No shortage of stents in the country: NPPAThe National Pharmaceutical Pricing Authority (NPPA) met stent makers and importers today to discuss issues like pricing and availability o...
- NPPA asks hospitals, stent makers to list prices on websitesThe instructions are being issued in public interest for compliance of ceiling prices by stent makers, distributors and hospitals, the NPPA...
- Hospitals can't refuse to sell patients the stents they demand: NPPAIn case of non-compliance of NPPA's instructions, the regulator said it may be constrained to invoke provisions of legal prosecution under ...
- Supply all stent brands, government tells companiesUnder the Section 3 (i) of DPCO, 2013, the govt can regulate distribution and direct any manufacturer to increase production and sell produ...
- 14 more medical devices may see price regulationThe National Pharmaceutical Pricing Authority (NPPA) has begun scrutiny of such devices, even asking makers to log in every detail about th...
- NPPA slashes margins on stents for hospitals, distributorsNow, patients purchasing stents at their maximum price won’t pay hospitals margins of more than Rs 2,400 on DES and BVS and about Rs 581 on...
- One in 3 stent implants in India is possibly unnecessaryThere is no regulation of hospitals in India, especially in the private sector where a majority of urban Indians seek healthcare.
- NPPA proposes to slash cardiac stent prices by 50%The body has proposed that ceiling prices of drug-eluting stents (DES) be fixed at rates ranging between Rs21,881 to Rs67,272—less than 50%...
- Indian cardiac stents as expensive as imports: MNC associationIndian stents are not drastically cheaper to imported stents, says the Medical Technology Association of India
- Cardiac stent prices dropped but patients charged high : IMS StudyThe report, coming in the backdrop of the government's moves to control prices of stents and other such medical devices.
- Capping cardiac stent prices gets NHSRC backingThe final parameters to fix prices of stents will be based on the findings in the NHSRC report and the price lists submitted by manufacture...
Load More
